SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ciphergen Biosystems(CIPH):
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who wrote (45)3/18/2002 8:14:23 PM
From: Biomaven  Read Replies (1) of 510
 
Ah - that makes things much clearer. Guess I should have read the S-1 to begin with.

I suspect that Hutchens did indeed sign on behalf of both parties - at the time of the agreement he was the principal shareholder of CTI as well as of MAS.

Note that this disagreement has been brewing for quite a while - from their very first S-1 filing:

We have received a letter from Molecular Analytical Systems expressing non-specific concerns that we are using the licensed technology in a manner that it claims exceeds the scope of the sublicense grants. Molecular Analytical Systems makes a further non-specific claim that we are misrepresenting the scope of our rights to third parties. We believe that this matter can be resolved satisfactorily.

Note that because Hutchens was on multiple sides of these agreements, CIPH gets some extra legal arguments that they seem to be taking advantage of.

Peter
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News